Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

TET2 Mutations Affect Non-CpG Island DNA Methylation at Enhancers and Transcription Factor-Binding Sites in Chronic Myelomonocytic Leukemia.

Yamazaki J, Jelinek J, Lu Y, Cesaroni M, Madzo J, Neumann F, He R, Taby R, Vasanthakumar A, Macrae T, Ostler KR, Kantarjian HM, Liang S, Estecio MR, Godley LA, Issa JP.

Cancer Res. 2015 Jul 15;75(14):2833-43. doi: 10.1158/0008-5472.CAN-14-0739. Epub 2015 May 13.

2.

Truncated DNMT3B isoform DNMT3B7 suppresses growth, induces differentiation, and alters DNA methylation in human neuroblastoma.

Ostler KR, Yang Q, Looney TJ, Zhang L, Vasanthakumar A, Tian Y, Kocherginsky M, Raimondi SL, DeMaio JG, Salwen HR, Gu S, Chlenski A, Naranjo A, Gill A, Peddinti R, Lahn BT, Cohn SL, Godley LA.

Cancer Res. 2012 Sep 15;72(18):4714-23. doi: 10.1158/0008-5472.CAN-12-0886. Epub 2012 Jul 18.

3.

Effects of TET2 mutations on DNA methylation in chronic myelomonocytic leukemia.

Yamazaki J, Taby R, Vasanthakumar A, Macrae T, Ostler KR, Shen L, Kantarjian HM, Estecio MR, Jelinek J, Godley LA, Issa JP.

Epigenetics. 2012 Feb;7(2):201-7. doi: 10.4161/epi.7.2.19015.

4.

Characterization of NOL7 gene point mutations, promoter methylation, and protein expression in cervical cancer.

Doçi CL, Mankame TP, Langerman A, Ostler KR, Kanteti R, Best T, Onel K, Godley LA, Salgia R, Lingen MW.

Int J Gynecol Pathol. 2012 Jan;31(1):15-24. doi: 10.1097/PGP.0b013e318220ba16.

5.

Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS/CTCF expression ratio and advanced stage.

Woloszynska-Read A, Zhang W, Yu J, Link PA, Mhawech-Fauceglia P, Collamat G, Akers SN, Ostler KR, Godley LA, Odunsi K, Karpf AR.

Clin Cancer Res. 2011 Apr 15;17(8):2170-80. doi: 10.1158/1078-0432.CCR-10-2315. Epub 2011 Feb 4.

6.

DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis.

Shah MY, Vasanthakumar A, Barnes NY, Figueroa ME, Kamp A, Hendrick C, Ostler KR, Davis EM, Lin S, Anastasi J, Le Beau MM, Moskowitz IP, Melnick A, Pytel P, Godley LA.

Cancer Res. 2010 Jul 15;70(14):5840-50. doi: 10.1158/0008-5472.CAN-10-0847. Epub 2010 Jun 29.

7.

Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines.

Yang Q, Tian Y, Ostler KR, Chlenski A, Guerrero LJ, Salwen HR, Godley LA, Cohn SL.

BMC Cancer. 2010 Jun 14;10:286. doi: 10.1186/1471-2407-10-286.

8.

The identification and characterisation of novel KIT transcripts in aggressive mast cell malignancies and normal CD34+ cells.

Ozer O, Zhao YD, Ostler KR, Akin C, Anastasi J, Vardiman JW, Godley LA.

Leuk Lymphoma. 2008 Aug;49(8):1567-77. doi: 10.1080/10428190802140865.

PMID:
18766971
9.

Implications of FLT3 mutations in the therapy of acute myeloid leukemia.

Mattison RJ, Ostler KR, Locke FL, Godley LA.

Rev Recent Clin Trials. 2007 May;2(2):135-41. Review.

PMID:
18473998
10.

Cancer cells express aberrant DNMT3B transcripts encoding truncated proteins.

Ostler KR, Davis EM, Payne SL, Gosalia BB, Expósito-Céspedes J, Le Beau MM, Godley LA.

Oncogene. 2007 Aug 16;26(38):5553-63. Epub 2007 Mar 12.

Supplemental Content

Loading ...
Support Center